Advertisement

Index by author

November 01, 2014; Volume 351,Issue 2

  1. Kakimoto, Tetsuhiro

    1. Analysis of the Effect of Canagliflozin on Renal Glucose Reabsorption and Progression of Hyperglycemia in Zucker Diabetic Fatty Rats
      Chiaki Kuriyama, Jun Zhi Xu, Seunghun Paul Lee, Jenson Qi, Hirotaka Kimata, Tetsuhiro Kakimoto, Keiko Nakayama, Yoshinori Watanabe, Nobuhiko Taniuchi, Kumiko Hikida, Yasuaki Matsushita, Kenji Arakawa, Akira Saito, Kiichiro Ueta and Masaharu Shiotani
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 423-431; DOI: https://doi.org/10.1124/jpet.114.217992

  2. Kassel, Karen M.

    1. Thrombin Inhibition with Dabigatran Protects against High-Fat Diet–Induced Fatty Liver Disease in Mice
      Anna K. Kopec, Nikita Joshi, Keara L. Towery, Karen M. Kassel, Bradley P. Sullivan, Matthew J. Flick and James P. Luyendyk
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 288-297; DOI: https://doi.org/10.1124/jpet.114.218545

  3. Kastenberger, Iris

    1. A Cycloartane Glycoside Derived from Actaea racemosa L. Modulates GABAA Receptors and Induces Pronounced Sedation in Mice
      Barbara Strommer, Sophia Khom, Iris Kastenberger, Serhat Sezai Cicek, Hermann Stuppner, Christoph Schwarzer and Steffen Hering
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 234-242; DOI: https://doi.org/10.1124/jpet.114.218024

  4. Kawas, Leen H.

    1. The Procognitive and Synaptogenic Effects of Angiotensin IV–Derived Peptides Are Dependent on Activation of the Hepatocyte Growth Factor/c-Met System
      Caroline C. Benoist, Leen H. Kawas, Mingyan Zhu, Katherine A. Tyson, Lori Stillmaker, Suzanne M. Appleyard, John W. Wright, Gary A. Wayman and Joseph W. Harding
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 390-402; DOI: https://doi.org/10.1124/jpet.114.218735

  5. Khom, Sophia

    1. A Cycloartane Glycoside Derived from Actaea racemosa L. Modulates GABAA Receptors and Induces Pronounced Sedation in Mice
      Barbara Strommer, Sophia Khom, Iris Kastenberger, Serhat Sezai Cicek, Hermann Stuppner, Christoph Schwarzer and Steffen Hering
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 234-242; DOI: https://doi.org/10.1124/jpet.114.218024

  6. Kimata, Hirotaka

    1. Analysis of the Effect of Canagliflozin on Renal Glucose Reabsorption and Progression of Hyperglycemia in Zucker Diabetic Fatty Rats
      Chiaki Kuriyama, Jun Zhi Xu, Seunghun Paul Lee, Jenson Qi, Hirotaka Kimata, Tetsuhiro Kakimoto, Keiko Nakayama, Yoshinori Watanabe, Nobuhiko Taniuchi, Kumiko Hikida, Yasuaki Matsushita, Kenji Arakawa, Akira Saito, Kiichiro Ueta and Masaharu Shiotani
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 423-431; DOI: https://doi.org/10.1124/jpet.114.217992

  7. Kleven, Daniel T.

    1. Combined Endothelin A Blockade and Chlorthalidone Treatment in a Rat Model of Metabolic Syndrome
      Chunhua Jin, Yejoo Jeon, Daniel T. Kleven, Jennifer S. Pollock, John J. White and David M. Pollock
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 467-473; DOI: https://doi.org/10.1124/jpet.114.215566

  8. Kopec, Anna K.

    1. Thrombin Inhibition with Dabigatran Protects against High-Fat Diet–Induced Fatty Liver Disease in Mice
      Anna K. Kopec, Nikita Joshi, Keara L. Towery, Karen M. Kassel, Bradley P. Sullivan, Matthew J. Flick and James P. Luyendyk
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 288-297; DOI: https://doi.org/10.1124/jpet.114.218545

  9. Kousik, Sharanya M.

    1. Dopamine Receptors and the Persistent Neurovascular Dysregulation Induced by Methamphetamine Self-Administration in Rats
      Sharanya M. Kousik, T. Celeste Napier, Ryan D. Ross, D. Rick Sumner and Paul M. Carvey
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 432-439; DOI: https://doi.org/10.1124/jpet.114.217802

  10. Kuo, M.-S.

    1. M1 and M2 Muscarinic Receptor Subtypes Regulate Antidepressant-Like Effects of the Rapidly Acting Antidepressant Scopolamine
      J. M. Witkin, C. Overshiner, X. Li, J. T. Catlow, G. N. Wishart, D. A. Schober, B. A. Heinz, A. Nikolayev, V. V. Tolstikov, W. H. Anderson, R. E. Higgs, M.-S. Kuo and C. C. Felder
      Journal of Pharmacology and Experimental Therapeutics November 2014, 351 (2) 448-456; DOI: https://doi.org/10.1124/jpet.114.216804
« Previous (Pages : 1 2 ... 2) Next »
Back to top

In this issue

Advertisement